B Campbell1, C Raherison2, C J Lodge1,3, A J Lowe1,3, T Gislason4,5, J Heinrich6,7, J Sunyer8,9,10, F Gómez Real11,12, D Norbäck13, M C Matheson1, M Wjst14, J Dratva15,16, R de Marco17, D Jarvis18, V Schlünssen19, C Janson11, B Leynaert20, C Svanes11, S C Dharmage1. 1. Allergy & Lung Health Unit, Centre for Epidemiology & Biostatistics, The University of Melbourne, Melbourne, Victoria, Australia. 2. Unité Epidémiologie et Biostatistique, Université Bordeaux Segalen, Bordeaux, France. 3. Murdoch Children's Research Institute, Melbourne, Australia. 4. Department of Respiratory Medicine and Sleep, Landspitali University Hospital, Reykjavik, Iceland. 5. Faculty of Medicine, University of Iceland, Reykjavik, Iceland. 6. Instititute of Epidemiology I, German Research Centre for Environmental Health, Helmholtz Zentrum München, Neuherberg, Germany. 7. Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, University Hospital Munich, Ludwig-Maximilians University Munich, Munich, Germany. 8. Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain. 9. CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain. 10. Departament de Ciències Experimentals i de la Salut (UPF), Universitat Pompeu Fabra, Barcelona, Spain. 11. Department of Occupational Medicine, Haukeland University Hospital, Bergen, Norway. 12. Centre for International Health, University of Bergen, Norway. 13. Department of Medical Sciences; Occupational and Environmental Medicine, Uppsala University, Uppsala, Sweden. 14. Institute of Lung Biology and Health (iLBD), Comprehensive Pneumology Center (CPC), Helmholtz Zentrum München, Munich-Neuherberg, Germany. 15. Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland. 16. University of Basel, Basel, Switzerland. 17. Epidemiology and Medical Statistics, University of Verona, Verona, Italy. 18. National Heart and Lung Institute, Imperial College, London, UK. 19. Section for Environment Occupation and Health, Department of Public Health, Aarhus University, Aarhus, Denmark. 20. Centre de Recherche Albert Bonniot, Grenoble, France.
Abstract
RATIONALE: Evidence has suggested that exposure to environmental or microbial biodiversity in early life may impact subsequent lung function and allergic disease risk. OBJECTIVES: To investigate the influence of childhood living environment and biodiversity indicators on atopy, asthma and lung function in adulthood. METHODS AND MEASUREMENTS: The European Community Respiratory Health Survey II investigated ∼10 201 participants aged 26-54 years from 14 countries, including participants' place of upbringing (farm, rural environment or inner city) before age 5 years. A 'biodiversity score' was created based on childhood exposure to cats, dogs, day care, bedroom sharing and older siblings. Associations with lung function, bronchial hyper-responsiveness (BHR), allergic sensitisation, asthma and rhinitis were analysed. MAIN RESULTS: As compared with a city upbringing, those with early-life farm exposure had less atopic sensitisation (adjusted OR 0.46, 95% CI 0.37 to 0.58), atopic BHR (0.54 (0.35 to 0.83)), atopic asthma (0.47 (0.28 to 0.81)) and atopic rhinitis (0.43 (0.32 to 0.57)), but not non-atopic outcomes. Less pronounced protective effects were observed for rural environment exposures. Women with a farm upbringing had higher FEV1 (adjusted difference 110 mL (64 to 157)), independent of sensitisation and asthma. In an inner city environment, a higher biodiversity score was related to less allergic sensitisation. CONCLUSIONS: This is the first study to report beneficial effects of growing up on a farm on adult FEV1. Our study confirmed the beneficial effects of early farm life on sensitisation, asthma and rhinitis, and found a similar association for BHR. In persons with an urban upbringing, a higher biodiversity score predicted less allergic sensitisation, but to a lesser magnitude than a childhood farm environment. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
RATIONALE: Evidence has suggested that exposure to environmental or microbial biodiversity in early life may impact subsequent lung function and allergic disease risk. OBJECTIVES: To investigate the influence of childhood living environment and biodiversity indicators on atopy, asthma and lung function in adulthood. METHODS AND MEASUREMENTS: The European Community Respiratory Health Survey II investigated ∼10 201 participants aged 26-54 years from 14 countries, including participants' place of upbringing (farm, rural environment or inner city) before age 5 years. A 'biodiversity score' was created based on childhood exposure to cats, dogs, day care, bedroom sharing and older siblings. Associations with lung function, bronchial hyper-responsiveness (BHR), allergic sensitisation, asthma and rhinitis were analysed. MAIN RESULTS: As compared with a city upbringing, those with early-life farm exposure had less atopic sensitisation (adjusted OR 0.46, 95% CI 0.37 to 0.58), atopic BHR (0.54 (0.35 to 0.83)), atopic asthma (0.47 (0.28 to 0.81)) and atopic rhinitis (0.43 (0.32 to 0.57)), but not non-atopic outcomes. Less pronounced protective effects were observed for rural environment exposures. Women with a farm upbringing had higher FEV1 (adjusted difference 110 mL (64 to 157)), independent of sensitisation and asthma. In an inner city environment, a higher biodiversity score was related to less allergic sensitisation. CONCLUSIONS: This is the first study to report beneficial effects of growing up on a farm on adult FEV1. Our study confirmed the beneficial effects of early farm life on sensitisation, asthma and rhinitis, and found a similar association for BHR. In persons with an urban upbringing, a higher biodiversity score predicted less allergic sensitisation, but to a lesser magnitude than a childhood farm environment. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Authors: Annah B Wyss; John S House; Jane A Hoppin; Marie Richards; John L Hankinson; Stuart Long; Paul K Henneberger; Laura E Beane Freeman; Dale P Sandler; Elizabeth Long O'Connell; Christie Barker Cummings; David M Umbach; Stephanie J London Journal: Thorax Date: 2017-07-08 Impact factor: 9.139
Authors: Niharika P Patel; Anna E Prizment; Bharat Thyagarajan; Evan Roberts; Heather H Nelson; Timothy R Church; DeAnn Lazovich Journal: Ann Allergy Asthma Immunol Date: 2018-04-06 Impact factor: 6.347
Authors: Danielle Boehmer; Barbara Schuster; Julia Krause; Ulf Darsow; Tilo Biedermann; Alexander Zink Journal: World Allergy Organ J Date: 2018-11-19 Impact factor: 4.084
Authors: Anne Vested; Ioannis Basinas; Alex Burdorf; Grethe Elholm; Dick J J Heederik; Gitte H Jacobsen; Henrik A Kolstad; Hans Kromhout; Øyvind Omland; Torben Sigsgaard; Ane M Thulstrup; Gunnar Toft; Jesper M Vestergaard; Inge M Wouters; Vivi Schlünssen Journal: Occup Environ Med Date: 2018-12-31 Impact factor: 4.402